You Have a Great Story

Menlo Park, CA

Akoya Biosciences’ history represents the rapid advancement driving the field of multiplexed biomarker analysis and immunofluorescence tissue analysis. Today’s Akoya portfolio spans the spectrum from powerful tools for discovery of important biomarkers to clinical research applications.

Houston, TX

Alzeca is focused on developing novel targeted MRI imaging agents for the early diagnosis of Alzheimer’s disease and other neurodegenerative disorders. The company’s proprietary technology is based on nanoparticles that specifically bind to abnormal proteins that accumulate in the brain years before significant cognitive symptoms appear.

San Diego, CA

Artelo is dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system.

Farmington, CT

Azitra, Inc. is a preclinical stage biotechnology company combining the power of the microbiome with cutting-edge genetic engineering to treat skin disease.

Paris, France

Bionest works to create competitive advantage for its clients by developing innovative and differentiated strategies at the corporate, portfolio and brand levels of medical and life science businesses. They also provide valuation and due diligence services to companies, investors and private equity.

Ann Arbor, MI

Celsee’s first product, the Genesis system, enables scientists to analyze and interpret cellular behavior and collect previously inaccessible information for improved results in applications such as proteogenomics, next-generation sequencing, immune monitoring, and cell therapy.

Mountain View, CA

DNAnexus^® has built the world’s most secure, trusted cloud platform and global network for scientific collaboration and accelerated discovery. We partner with customers to tackle the world’s most exciting opportunities in human health and beyond.

San Diego, CA

EpicentRx is a patient-driven oncology company developing new mechanisms of immunotherapy that work across diverse patient populations and tumor types with minimal toxicity, enabling the best-possible quality of life during treatment.

Burnaby, British Columbia

Fusion Genomics is a molecular diagnostics company focused on transforming infectious disease through advanced genomic technologies.

San Carlos, CA

GALT is a leading developer of next-generation cultivation platforms for microbiome research and microbial product development, addressing high-impact markets including human health, agriculture, environmental science, and microbial products for industrial use.

Orlando, FL

Hesperos has develops a tool to characterize an individual’s biology with human-on-a-chip microfluidic systems. With a mission to revolutionize toxicology testing as well as efficacy evaluation for drug discovery, the company has created pumpless platforms with serum-free cellular mediums that allow multi-organ system communication and integrated computational modeling of live physiological responses of functional neurons, cardiac, muscle, and neuromuscular junctions as well as liver, pancreas and barrier tissues.

Shenzen, China

HighTide Therapeutics is a global clinical-stage biopharmaceutical company focused on discovering and developing novel drugs to treat chronic liver diseases, gastrointestinal diseases and metabolic disorders with high unmet needs.

San Diego, CA

Scientists around the world use the company's RIPTIDE® High-Throughput Rapid Library Prep to maximize laboratory capacity and statistical power for applications in population genetics, agrigenomics, microbiome, and synthetic biology.

Boulder, CO

Inscripta is a gene-editing technology company that puts researchers in control by making it easy for them to get all they need for cutting-edge, forward cell-engineering. These tools include a family of CRISPR enzymes (called MADzymes), custom nucleases for researchers and commercial partners, and a full suite of gene-editing tools.

Austin, TX

Luminex aims to transform global healthcare and life science research through the development, manufacturing, and marketing of proprietary instruments and assays that deliver cost-effective, rapid results to clinicians and researchers.

Emeryville, CA

Founded by physicists from the University of California-Berkeley and Lawrence Berkeley National Laboratory, Nanōmix is developing the next generation of mobile, point-of-care medical diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings.

Boston, MA

NanoView provides direct from sample, label-free characterization of extracellular vesicles with no purification required. The platform will assist in the translation of extracellular vesicle research into the clinical and therapeutic environment.

Madison, WI

Stemina markets its ASD diagnostics through its neurological disorders division, NeuroPointDX. Their metabolomics-based tool assists with the diagnosis of autism spectrum disorder and is also relevant to other neurological disorders that are notoriously difficult to diagnose and treat, including schizophrenia, depression, and anxiety.

New York, NY

Oligomerix is an emerging biotechnology company focused on discovering and developing novel, small-molecule inhibitors of tau oligomer formation for Alzheimer’s disease (AD) and related neurodegenerative diseases with tau pathology.

Santa Cruz, CA

Ontera was founded with the idea that better information is needed to enhance human and environmental health in a sustainable way. The company aims to revolutionize diagnostics with its single-molecule detection and genome analysis platforms based on proprietary biochemistry and silicon nanopore chip-based sensors.

Wellesley, Mass and Reston, VA

Outcome Capital is a unique investment banking firm that provides middle-market growth companies in the life sciences, healthcare services and technology markets with a value-added client-centric approach to merger, acquisition and corporate finance advisory services.

Menlo Park, CA

Pacific Biosciences in transforming the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.

Pleasanton, CA

Purigen Biosystems is redefining nucleic acid sample preparation with an innovative platform based on the highly efficient isotachophoresis technology invented by a team of scientists at Stanford University.

Seattle, WA

Resolution is dedicated to developing a highly sensitive, non-invasive liquid biopsy platform that improves cancer diagnostics and monitoring for patients around the world.

Stamford, CT

Sema4 is a next-generation health information company, spun out of the Mount Sinai Health System, that provides advanced genomic testing and merges big data analytics with clinical diagnostics.

San Francisco, CA

Shasqi, Inc., founded in 2018, is a privately held company focused on developing cancer treatments using bioorthogonal “click” chemistry for localized drug delivery. Shasqi’s treatments employ activating agents in an injected biomaterial to concentrate and activate systemic prodrug versions of cancer drugs directly at the tumor site.

Menlo Park, CA

Strateos is the leading provider of on-demand discovery science. The company automates medicinal chemistry and biological analyses into closed-loop robotic labs that accelerate discovery programs for researchers around the world.

Los Angeles, CA

The Department of Translational Genomics brings to bear vast experience and expertise in molecular genetics, genome science, biomedical informatics, translational science, and molecular medicine.

Allakos • Aravive • Association for Molecular Pathology • Applied Biosystems • BD Biosciences • Benchling • Biotique Systems • Caladrius • Cellular Research • Chiron Corporation • Connetics • Cynvenio Biosystems • DNAnexus • DoubleTwist • Eos • Eurofins Genomics • Gen9 • GE healthymagination • Genentech • GenoSpectra • IDbyDNA • IntegenX • Invitrogen • Kapa Biosystems • Labcyte • Medcision • Microsoft Health Solutions • Medtronic • Mohr Davidow Ventures • NanoString Technologies • Nektar • Omicia • Osel • PAG • PaxVax • Personalis • Protagonist • QIAGEN Bioinformatics • RainDance Technologies • Sage Science • StationX • Tetra Therapeutics • twoXAR • Varian Medical Systems • VitaPath Genetics • Xcell Biosciences • Zyomyx